Found: 10
Select item for more details and to access through your institution.
Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Modular therapy approach in metastatic castration-refractory prostate cancer.
- Published in:
- World Journal of Urology, 2010, v. 28, n. 6, p. 745, doi. 10.1007/s00345-010-0567-x
- By:
- Publication type:
- Article
Biomodulatory metronomic therapy in stage IV melanoma is well-tolerated and may induce prolonged progression-free survival, a phase I trial.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2016, v. 30, n. 11, p. e119, doi. 10.1111/jdv.13391
- By:
- Publication type:
- Article
Case report: Sustained complete remission with all-oral MEPED therapy in a patient with Hodgkin's disease developing resistance to pembrolizumab.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1334233
- By:
- Publication type:
- Article
Complexity of PEComas: Diagnostic approach, molecular background, clinical management.
- Published in:
- Der Pathologe, 2020, v. 41, n. 1, p. 9, doi. 10.1007/s00292-019-0612-5
- By:
- Publication type:
- Article
Erratum zu: Komplexität von PEComen: Diagnose, Molekulargenetik, klinisches Management.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Komplexität von PEComen: Diagnose, Molekulargenetik, klinisches Management.
- Published in:
- Der Pathologe, 2019, v. 40, n. 4, p. 443, doi. 10.1007/s00292-019-0614-3
- By:
- Publication type:
- Article
The relation between dyadic coping and relationship satisfaction in couples dealing with haematological cancer.
- Published in:
- European Journal of Cancer Care, 2018, v. 27, n. 1, p. 1, doi. 10.1111/ecc.12595
- By:
- Publication type:
- Article
Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial.
- Published in:
- Medical Oncology, 2012, v. 29, n. 2, p. 799, doi. 10.1007/s12032-011-9982-0
- By:
- Publication type:
- Article